Trials / Completed
CompletedNCT04492319
Addition of Neostigmine to Levobupivacaine
The Effect of Addition of Neostigmine to Levobupivacaine in Male Patients Receiving Ultrasound Guided Spermatic Cord Block for Postoperative Analgesia in Testicular Sperm Extraction Surgery:
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 112 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Male
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Using the spermatic cord block has been of great advantage, as it has been cost saving, efficient technique whether used inon its own or combination with a sedative or . Furthermore, it provides minimal cardiac risks, early case ambulation, satisfactory postoperative pain control, as well as a reduced hospital stay and cost. one of the major drawbacks of spermatic cord block is being a single injection technique, leading to a short postoperative analgesia duration. So, to overcome this flaw some adjuvants were proven to prolong the analgesia duration as neostigmine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Control Test | spermatic cord block by 19 ml Levobupivacaine 0.5% plus 1 ml 0.9 normal saline in each side |
| DRUG | Neostigmine | spermatic cord block by 19 ml Levobupivacaine 0.5% plus 1 ml neostigmine 500 μg in each side . |
Timeline
- Start date
- 2020-09-29
- Primary completion
- 2023-11-23
- Completion
- 2023-12-20
- First posted
- 2020-07-30
- Last updated
- 2024-01-09
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04492319. Inclusion in this directory is not an endorsement.